Abstract
Purpose Role of intravitreal injection of dexamethasone implant (Ozurdex) for refractory macular thickening. Methods A case report of a 13-year-old boy with Rhodopsin-positive, CRB1-negative retinitis pigmentosa presenting with Coat’s-like exudative vitreoretinopathy and treatment-resistant cystoid macular oedema. Results A reduction in the macular thickening following a single injection of Ozurdex. Conclusion We present our experience in successful treatment of refractory macular oedema with intravitreal injection of dexamethasone implant resulting in clinically significant resolution of macular thickening.

This publication has 9 references indexed in Scilit: